Certificate Number,Certificate
BE/GMP/2022/074,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BG/GMP/2022/213,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms: sachet(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: inhalers(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms: sachet(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: inhalers(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0169,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
13-Feb,
14-Feb,
15-Feb,
DE_HE_01_GMP_2022_0147,
FIMEA/2022/001286,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
OGYÉI/514-6/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: Lozenges(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Lozenges(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/496-6/2022,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Oncological(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Powder for oral solution(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powder for oral solution(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/496-7/2022,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Oncological(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Powder for oral solution(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powder for oral solution(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
203/10,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
DE_BY_05_GMP_2022_0057,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
DE_HE_01_GMP_2022_0180,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0163,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FT020/MH/001/2023,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 1  B-lactam Antibiotics 1.1.1.6  Other: Dry powders for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Lyophilisates and dry powders for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT020/MH/002/2023,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 1  B-lactam Antibiotics 1.1.1.6  Other: Dry powders for injection(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT020/SA/001/2023,
22-324585,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biololgical active starting materials(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HH_01_GMP_2022_0013,
IT/GMP/E/02/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BY_05_GMP_2022_0052,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/29301-6/2022,
OGYÉI/21402-6/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/39107-7/2022,
39/10,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: eye drops(en) 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.110.2022.IP.1 WTC/0614_03_01/249,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.110.2022.IP.2 WTC/0614_03_02/250,
MT/034HM/2023,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
MT/057HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: oral powder in unit dose forms (sachets)(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: oral powder in unit dosage forms (sachets)(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NL/H 22/2042232 A,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0205,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
BE/GMP/2022/063,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0091,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
IWSF.405.105.2022.IP.1 WTC/0598_01_01/242,
NL/HV 22/2042107,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
151/8,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
151/9,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
6.2.1-2022-041299,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0092,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0114,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacturing of CBD Isolate (crystals)(en)
OGYÉI/3315-6/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Oncological(en) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Oncological(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: Oncological(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
6.2.1-2022-021720,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2022_0118,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DK H 00114519,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK H 10000550,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products Special Requirements               : 7  Other: Heparin formulation and filling(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/25631-6/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Sachet(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Sachet(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/25840-4/2022,
32122,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
32122 (2),1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage(en)
DE_HE_01_GMP_2022_0089,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
530-10/22-05/02; 381-13-08/337-22-13,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: Inhalation powder, hard capsule(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Inhalation powder, hard capsule(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
SK/013V/2022,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/031HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
Sk/026V/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
2022/32080,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Cell bank storage(en)
sukls61217/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
032/2022/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: : film-coated tablets, enteric coated tablets, powders for oral solution(en) 1.2.1.13  Tablets 1.2.1.17  Other: pellets/ capsules with pellets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: : film-coated tablets, enteric coated tablets, powders for oral solution(en) 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: pellets/ capsules with pellets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2022/32078,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2022/051,
DE_HE_01_GMP_2022_0087,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation.(en)
MT/039HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NL/H 23/2043139,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
SK/016V/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
6.2.1-2022-037001,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological bulk drug substance and biological active starting materials(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
6.2.1-2022-037002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological bulk drug substance(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0108,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
BG/GMP/2022/212,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for solution for injection-cephalosporins.(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0090,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
IWSF.405.93.2022.IP.1 WTC/0342_01_01/215,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: lyophilisates(en) 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Other: Biological active substance(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: lyophilisates(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.93.2022.IP.2 WTC/0342_02_01/216,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
MT/055HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
SK/015V/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
002/2023/RO,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: film-coated tablets, powders for oral solutions(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: pellets/ capsules with pellets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: film-coated tablets, powders for oral solutions(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: pellets/ capsules with pellets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BG/GMP/2022/210,
IT/E/API/01/2023,
IT/GMP/E/01/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Othes aseptically prepared products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
151/2022/GMP,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids Special Requirements               : 1  B-lactam Antibiotics 7  Other: hormonal products(en) 1.1.1.4  Small volume liquids Special Requirements               : 1  B-lactam Antibiotics 7  Other: hormonal products(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: intramammary tubes and eye preparations(en) Special Requirements               : 1  B-lactam Antibiotics 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices Special Requirements               : 6  Ectoparasiticides 1.2.1.5  Liquids for external use Special Requirements               : 6  Ectoparasiticides 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: oral powders, oral granules(en) Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets 1.2.2  Batch certification 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
OGYÉI/19937-6/2022,
90/10,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
90/11,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
90/7,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
90/8,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
90/9,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
BG/GMP/2022/209,
BE/GMP/2022/057,
OGYÉI/17243-6/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids Special Requirements               : 7  Other: Antibiotics(en) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: Antibiotics(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
22-320078,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ES/100HV/22,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Manufacture of sterile active substances and intermediates(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
ES/107HV/22,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Manufacture of sterile active substances and intermediates(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2022_0101,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_BW_01_GMP_2022_0065,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: - Release of primary packaged drug product Ebvallo (Tabelecleucel; allogeneic cytotoxic T Cell suspension, sterile, cryopreserved) for export to EU - Archiving of related batch documentation(en)"
DE_BW_01_GMP_2022_0094,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2022/048,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.8  Other: Biological active starting materials(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_SH_01_GMP_2022_0018,
DE_BW_01_GMP_2022_0092,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
DE_BW_01_GMP_2022_0093,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
DE_HH_01_GMP_2022_0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Sterile ophthalmic solution for topical use(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
UP/I-530-10/22-03/14; 381-13-08/241-22-03,
2022_HPF_PT_006_IV,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility
DE_HE_01_GMP_2022_0057,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
CH22-0066,
2023_HPF_PT_002,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.12  Suppositories 1.2.1.17  Other: inhalation vapour, emulsion(en) 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
ES/104/22,
ES/105HV/22,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Paracetamol granules for direct compression (intermediate product)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Bulk Packaging(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT090/S1/MH/001/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT090/S1/MH/002/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Film coated tablets(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Film coated tablets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_ST_01_GMP_2022_0036,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical"
BG/GMP/2022/211,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Sachet(en) 1.2.1.13  Tablets 1.2.1.17  Other: film-coated tablets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Sachet(en) 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: film-coated tablets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/021HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
147/2022/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids Special Requirements               : 1  B-lactam Antibiotics 1.1.1.4  Small volume liquids Special Requirements               : 1  B-lactam Antibiotics 7  Other: hormonal(en) 1.1.1.5  Solids and implants 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids Special Requirements               : 1  B-lactam Antibiotics 1.1.2.5  Other: intramammary and intrauterine(en) Special Requirements               : 1  B-lactam Antibiotics 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use Special Requirements               : 6  Ectoparasiticides 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder for oral solution(en) Special Requirements               : 1  B-lactam Antibiotics 1.2.2  Batch certification 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
409-2/2021-8,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.17  Other: Pessaries(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Pessaries(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0093,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
OGYÉI/25107-3/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
409-4/2021-10,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Pessaries(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Pessaries(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
409-4/2021-11,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.8  Other solid dosage forms: film-coated tablets, powders and granules for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.5.1.8  Other solid dosage forms: film-coated tablets, powders and granules for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging"
OGYÉI/15395-2/2023,
OGYÉI/21847-4/2022,
029/2022/RO,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/12037-4/2022,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/12037-5/2022,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2022/049,
DE_HE_01_GMP_2022_0096,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_NI_04_GMP_2022_0011,
DE_NI_04_GMP_2023_0015,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging
sukls46835/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: hormones(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: hormones(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
sukls79526/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
001/2023/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: film-coated tablets(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: film coated tablets(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0099,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
OGYÉI/12690-6/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Powders and granules (sachets)(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
ES/062HV/22,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
31749,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
33650,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
MT/027HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.3  Chewing gums 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.3  Chewing gums 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
169/5,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
DE_HE_01_GMP_2022_0146,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0209,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0109,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
OGYÉI/28866-5/2022,
FT089/MH/001/2023,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.6  Other: Dry powder for solution for injection(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Lyophilisates(en) Special Requirements               : 7  Other: Dry powder for solution for injection(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
MT/026HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Intermediates (granules for direct compression)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/029HM/2022,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of raw materials and intermediates (granules for direct compression)(en)
OGYÉI/22100-4/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/045HV/22,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
56/11,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: sampling, relabelling of primary containers(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
56/12,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: sampling, relabelling of primary containers(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
NL/H 22/2040798,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2022/062,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.3  Chewing gums 1.2.1.5  Liquids for external use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_NW_03_GMP_2022_0065,
DE_ST_01_GMP_2022_0035,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IWSF.405.68.2022.IP.1 WTC/0625_01_01/140,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NL/H 22/2040793,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
OGYÉI/25104-3/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NL/H 22/2040770AA,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Preparation of working cell bank(en) 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacture and Storage of MCB/WCB(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BG/GMP/2022/206,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 22/2040770BB,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage of MCB/WCB(en)(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NL/H 22/2040767,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Master and working cell banks(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
CERT 2009-040/2022,
OGYÉI/10747-6/2022,
OGYÉI/10747-8/2022,
12-Jan,
13-Jan,
42/12,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.8  Other solid dosage forms: powders, pellets(en) 1.2.1.13  Tablets 1.2.1.17  Other: periodontal inserts(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: powders and granules (in sachets)(en) 1.5.1.17  Other non-sterile medicinal products: periodontal inserts(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
DE_HE_01_GMP_2022_0051,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2022_0095,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
OGYÉI/4680-7/2022,
6.2.1-2022-056744,
31783,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
37/9,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: powders, granules, foams(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: powders, granules, foams(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0045,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
013/2024/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: film-coated tablets, coated tablets, granules for oral suspension, powders for oral solution, gastroresistant tablets, prolonged release tablets, compressed lozenges(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: granules for oral suspension, powders for oral solution(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
CG-HU/05V/2022.,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
012/2024/RO,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: film-coated tablets, oral dispersable tablets, gastroresistant tablets, prolonged release tablets(en) 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: biosimilar products(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: film-coated tablets, oral dispersable tablets, gastroresistant tablets, prolonged release tablets(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
FT088/S1/MH/001/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets Special Requirements               : 7  Other: Chewable tablet; Film coated tablets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets Special Requirements               : 7  Other: Chewable tablet; Film coated tablets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/002HM/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
146/2022/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0048,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2022_0097,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2023_0045,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_ST_01_GMP_2022_0048,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormones(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: Hormones(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
76/7,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products
DE_HE_01_GMP_2022_0075,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation.(en)
DE_HE_01_GMP_2022_0110,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0098,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting material: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0049,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2022_0073,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0143,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DK H 10000434,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0085,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
ES/037HV/22,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.8  Other: manufacturing of biological active substances(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/80779-6/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Sachet - Powder for Oral Solution(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Sachet - Powder for Oral Solution(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0140,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
MT/032HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2022_HPF_PT_004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2022/032,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
BG/GMP/2022/214,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: solutions, spray, drops(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: drops, solutions, syrup, suspension(en) 1.2.1.8  Other solid dosage forms: - powders for oral solution(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: ointment, cream, gel, liniment(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: tablets, subligual tablets, Special requirements-cytostatics, hormone(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use Special Requirements               : 7  Other: solutions, spray, drops(en) 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: drops, solutions, syrup, suspension(en) 1.5.1.8  Other solid dosage forms: powders for oral solution(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0141,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_SL_01_GMP_2022_0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Active substances: - Cefuroxime-sodium powder sterile - Cefuroxime axetil powder(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2022_0088,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0106,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0139,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0011,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0069,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
MT/014HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
150/2022/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Blister with antigen inserted into edible bait(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.44.2022.IP.1 WTC/0626_02_01/71,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.49.2022.MP.1 WTC/0456_01_01/78,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2022_0142,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_NI_04_GMP_41401-17/31_2,
FIMEA/2021/006984,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2022_0107,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0112,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
DE_HE_01_GMP_2022_0145,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_HE_01_GMP_2022_0005,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_BW_01_GMP_2022_0041,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Active pharmaceutical ingredients pre-mix, herbal origin: Aged Garlic Extract Powder Pre-Mix(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_SH_01_GMP_2022_0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms
DE_HE_01_GMP_2022_0074,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
91/5,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
137/12,
BG/GMP/2022/198,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2022_HPF_PT_002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
2022_HPF_PT_003,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage of Master Cell Bank and/or Working Cell Bank(en)
DE_HE_01_GMP_2022_0010,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
47/7,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes 1.2.1.17  Other: water soluble powders for oral use(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.16  Veterinary premixes 1.5.1.17  Other non-sterile medicinal products: water soluble powders for oral use(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
47/8,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.16  Veterinary premixes 1.2.1.17  Other: water soluble powders for oral use(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.16  Veterinary premixes 1.5.1.17  Other non-sterile medicinal products: water soluble powders for oral use(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DE_HE_01_GMP_2022_0071,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
31530,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
32242,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
DE_HE_01_GMP_2022_0006,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
484162-100012447-17283566,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
484162-100012447-17539000,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_SL_01_GMP_2022_0001,
IWSF.405.36.2022.IP.1 WTC/0383_02_01/54,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/1623-4/2022.,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: Tablets and Filmcoated tablets.(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: Tablets and Filmcoated tablets.(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/22-03/10; 381-13-08/243-22-03,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2022_0113,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
006/2022/RO,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: film coated tablets, powders for oral solutions/suspensions(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: film coated tablets, powders for oral solutions/suspensions(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
ES/026HV/22,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
21/31236-4,
DE_HE_01_GMP_2022_0072,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation(en)
DE_SN_01_GMP_2022_0015,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Cytostatics(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
MT/005HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Powders/granules for oral suspension(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/66586-6/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
22/310972,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
NL/H 22/2035833,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls256354/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BY_05_GMP_2022_0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2021/149,
UP/I-530-10/22-03/12; 381-13-08/310-22-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
113/5,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.1  Site of physical importation
NL/H 21/2035797,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: suspension for infusion(en) Special Requirements               : 3  Live Cells 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products Special Requirements               : 3  Live Cells 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2022_0094,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human-plasma for fractionation(en)
BE/GMP/2021/148,
14/8,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2021-MB-046HPT01,
2022_HPF_PT_001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
6.2.1-2022-027499,
409-4/2020-9,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FIMEA/2019/000085,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging"
DE_HE_01_GMP_2021_0125,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
229/4,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Sachets, Combination products(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Sachets, Combination products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
ES/028/22,
31510,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
ES/017/22,
141/2021/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Blister with antigen inserted into edible bait(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
14/7,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
199/5,"2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Radiopharmaceuticals/radionuclide generators, Herbal products(en)"
199/6,
199/7,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Radiopharmaceuticals/radionuclide generators, Herbal products(en)"
199/8,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Radiopharmaceuticals/radionuclide generators, Herbal products(en)"
013/2022/RO,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
14-Jun,
IT/E/API/02/2022,
sukls271609/2021,
21/24860-10,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/NC/2022/01,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Manufacture of non-sterile biological drug substance(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
BG/GMP/2021/191,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_NW_03_GMP_2022_0011,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products 1.5.2  Secondary packaging
92/6,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.6  Electron beam 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Fibrin pad(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BG/GMP/2022/218,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging
UP/I-530-10/22-03/08; 381-13-08/284-22-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging"
2021-MB-048HPT01,
33/8,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.3  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared
DE_RP_01_GMP_2022_0022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_RP_01_GMP_2022_0024,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.5.2022.IP.1 WTC/0624_01_01/32,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula.(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula.(en) 1.5.2  Secondary packaging
IWSF.405.5.2022.IP.2 WTC/0624_01_02/33,
482794-14245633,
BG/GMP/2021/193,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: beta lactam antibiotic-powder for injection(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use Special Requirements               : 7  Other: spray(en) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: syrups, oral suspensions(en) 1.2.1.8  Other solid dosage forms: powder for oral suspension, granules for oromucosal suspension,effervescent granules(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: cream, ointment, gel(en) 1.2.1.13  Tablets 1.2.1.17  Other: film-coated tablets, coated tablets, gastro-resistant tablets, gastro-resistant capsules, lozenges(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: beta-lactam antibiotics – cephalosporines: film-coated tablets; powder for oral suspension(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: film-coated tablets, coated tablets, gastro-resistant tablets, gastro-resistant capsules, lozenges, powder for oral suspension , granules for oromucosal suspension, effervescent granules, cephalosporines:film-coated tablets, powder for oral suspension(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DK H 10000426,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
484163-14245554,
95/10,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radioactive products(en) 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.10  Radionuclide generators 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.8  Other: Radiopharmaceuticals / Radionuclide generators(en)
95/12,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radioactive products(en) 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.10  Radionuclide generators 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Radiopharmaceuticals / Radionuclide generators(en)
95/13,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radioactive products(en) 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.10  Radionuclide generators 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Radiopharmaceuticals / Radionuclide generators(en)
2022_HPF_PT_005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
35/11,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
35/7,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
35/8,
35/9,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
136/11,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.136.2021.IP.1 WTC/0614_02_01/345,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UP/I-530-10/22-03/06; 381-13-08/243-22-03,
IT/E/API/01/2022,
BG/GMP/2021/189,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: Solution for injection in cartridge; Suspension for injection in cartridge;Solution for injection in pre-filled injector;Suspension for injection in pre-filled injector.(en) 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0124,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
139/2021/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0115,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DK H 10000339,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK V 10000341,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK V 10000342,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/72/H/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Granules(en) 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
138/2021/GMP,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
30769,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
DE_HE_01_GMP_2021_0101,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
2021-MB-041,
OGYÉI/29981-5/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/47379-6/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Syrup(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Syrup(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/51572-6/2021,
MT/001HM/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_BW_01_GMP_2022_0091,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use
IWSF.405.125.2021.IP.1 WTC/0594_01_02/333,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula.(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula.(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.125.2021.IP.2 WTC/0594_01_01/334,
DE_RP_01_GMP_2021_0032,
DE_NW_01_GMP_2021_0024,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacturing, primary and secondary packaging of Cannabis extracts adjusted with olive oil after extraction of Cannabis flowers and chopped herb with supercritical carbondioxide.(en)"
SK/012V/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Small volume aseptically filled eyedrops and small volume aseptically filled oral solutions(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2021/31299,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
2021/31300,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Master cell bank and working cell bank manufacturing(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
2021/31301&31302,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Cell bank storage(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/47378-6/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
136/2021/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Ectoparasicides for external use(en) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_NW_01_GMP_2021_0023,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacturing, primary and secondary packaging of Cannabis flowers, not irradiated(en)"
DE_BW_01_GMP_2023_0179,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FIMEA/2021/001610,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FIMEA/2020/000982,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
SK/011V/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0102,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
20/9,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders (including powders of Penicillins)(en) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders (including powders of Penicillins)(en) 1.5.1.16  Veterinary premixes 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ES/170HV/21**,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.6  Other: manufacturing of sterile active substances and powder for injection(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
31269,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage of Master Cell Banks and Working Cell Banks(en)
IT/E/API/05/2021,
MT/030HW/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: pellets(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: pellets(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2021_0103,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
147/6,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
147/7,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
147/9,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0091,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
OGYÉI/38172-7/2021,
75/7,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: biological skin tests, contrast media(en) 2.3  Other importation activities 2.3.1  Site of physical importation"
DE_ST_01_GMP_2022_0043,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 2  Other highly sensitising materials 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 2  Other highly sensitising materials 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_ST_01_GMP_2022_0044,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/E/API/04/2021,
OGYÉI/35791-6/2021,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/79191-2/2021,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powder for oral suspension(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
29/07/2021*,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
23-Apr,
DE_BW_01_GMP_2021_0154,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0100,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_ST_01_GMP_2022_0031,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ES/143HV/21,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/37194-7/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Ointment(en) 1.2.1.17  Other: Inhaler(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Ointment(en) 1.5.1.17  Other non-sterile medicinal products: Inhaler(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_ST_01_GMP_2022_0012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: liquid for nebuliser(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_BW_01_GMP_2021_0172,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging"
ES/123HV/21,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility
149/7,
21/303011,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation Special Requirements               : 7  Other: GUARDIAN SR Injectable – Ivermectin microspheres (powder)(en)
OGYÉI/37186-8/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: Lozenges(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Lozenges(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/41154-6/2021,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/41154-8/2021,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT/E/API/03/2021,
164/5,
164/6,
164/7,
DE_HE_01_GMP_2023_0264,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.102.2021.IP.1 WTC/0489_01_01/266,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
INS/GMP/2019/106,
UP/I-530-10/21-03/10; 381-13-08/243-21-03,
132/6,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
256/2,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.6  Electron beam
256/3,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.6  Electron beam Special Requirements               : 7  Other: (for bioburden reduction, see clarifying remarks section)(en) 1.4.3  Other: Batch certification(en)"
256/4,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.6  Electron beam Special Requirements               : 7  Other: (for bioburden reduction, see clarifying remarks section)(en) 1.4.3  Other: Batch certification(en)"
256/5,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.6  Electron beam Special Requirements               : 7  Other: (for bioburden reduction, see clarifying remarks section)(en) 1.4.3  Other: Batch certification(en)"
DE_RP_01_GMP_2021_0035,
133/2021/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
FT064/S1/MH/001/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Granules(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Granules(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT064/S1/MH/001/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Granules(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Granules(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT064/S1/MH/001/2023,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Granules(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Granules(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IT/E/API/02/2021,
132/2021/GMP,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.2.5  Other: intramammary suspensions, betalactams(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Ectoparasicides for external use(en) 1.2.1.9  Pressurised preparations 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UP/I-530-10/21-03/14; 381-13-08/310-22-09,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powder for oral suspension (filled in bottles and sachets)(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powder for oral suspension (filled in bottles and sachets)(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
145/3,
DE_SH_01_GMP_2023_0017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
36/6,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products
36/7,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Radiopharmaceuticals/Radionuclide generators(en)
36/8,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Radiopharmaceuticals/Radionuclide generators(en)
DE_HE_01_GMP_2021_0069,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2021_0070,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
8-Mar,
53/10,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders(en) 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: bulks of non sterile products are imported, tested and packed(en)"
53/7,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powders(en) 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: bulks of non sterile products are imported, tested and packed (primary and/or secondary)(en)"
53/8,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: bulks of non sterile products are imported, tested and packed (primary and/or secondary)(en)"
53/9,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: bulks of non sterile products are imported, tested and packed (primary and/or secondary)(en)"
DK H 10000245,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0054,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
ES/023HV/22,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
222/3,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
44/7,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
ES/187/21,
238/2,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
CERT 1997-066/2021,
DE_HE_01_GMP_2021_0055,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2021_0099,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: granules and granules for oral suspensions(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: granules and granules for oral suspensions(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IWSF.405.82.2021.IP.1 WTC/0615_01_01/208,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/7291-10/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
158/8,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Lutetium-177 sterile radionuclides(en) 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.3  Other importation activities 2.3.4  Other: Radiopharmaceuticals/Radionuclide generators (radiopharmaceutical precursor, sterile solution)(en)"
UP/I-530-10/21-03/13; 381-13-08/318-21-03,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: hormones(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: hormones(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell Special Requirements               : 7  Other: hormones(en) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: hormones(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: hormones(en) 1.2.1.17  Other: Powders/granules for oral solution in sachets(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell Special Requirements               : 7  Other: hormones(en) 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: hormones(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: hormones(en) 1.5.1.17  Other non-sterile medicinal products: Powders/granules for oral solution in sachets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
30766,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/088HV/21,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.8  Other: Biological Active Substance and Pharmaceutical Intermediate in Bulk(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSF.405.65.2021.IP.1 WTC/0614_01_01/185,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UP/I-530-10/21-03/11; 381-13-08/337-21-03,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.2.1.17  Other: Powder for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.1.17  Other non-sterile medicinal products: Powder for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
30759,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2021_0035,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/101HV/21,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.8  Other: Biological active substance and bulk drug product intermediate(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
OGYÉI/22135-6/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use Special Requirements               : 7  Other: Syrups and suspensions(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Other(en) Special Requirements               : 7  Other: Powder for oral suspension(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use Special Requirements               : 7  Other: Syrups and suspensions(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products Special Requirements               : 7  Other: Powder for oral suspension(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UP/I-530-10/21-03/12 ; 381-13-08/310-21-03,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FIMEA/2021/002101,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: manufacturer of biological active pharmaceutical substance(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0053,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
OGYÉI/19179-6/2021,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
OGYÉI/15655-6/2021,
30709,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
IT/GMP/E/02/2021,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0052,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
IWSF.405.46.2021.IP.1 WTC/0602_01_01/147,
№ BG/GMP/2021/180,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: active substance/excipient(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
129/2021/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
130/2021/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: oral powders(en) 1.2.1.16  Veterinary premixes 1.2.1.17  Other: granule(en)
OGYÉI/14354-7/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2021_0051,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2021_0038,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
OGYÉI/50486-5/2021,
230/4,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.3  Other: Lyophilisiation of active substance of another party(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
230/6,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: lyophilization of active substance(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
230/7,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: lyophilization of active substance(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_SL_01_GMP_2021_0025,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for injection(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
226/3,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: herbal products(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
226/4,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
OGYÉI/14815-7/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0044,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2021/HPF/PT/003/evd,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging
sukls34144/2021,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: biotechnologically manufactured active pharmaceutical ingredients(en)
224/4,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.4  Other: herbal products, biological active substances(en)"
224/5,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: herbal products, biological active substances, comperators(en)"
224/6,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: herbal products, biological active substances, comperators(en)"
DE_RP_01_GMP_2021_0009,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Active Pharmaceutical Ingredients (chemical synthesis)(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
ES/098HV/21b,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2021/HPF/PT/005/evd,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2021_0032,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
ES/117HV/21,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
13/15,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
13/16,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
13/17,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.3  Other: Master cell bank & working cell bank including storage(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
13/19,"1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: 2.3.2 : importation of naked vials, manufactured by a contract manufacturer(en)"
DE_HE_01_GMP_2023_0175,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
BE/GMP/2021/035,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility
DE_HE_01_GMP_2021_0030,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
NL/H 21/2028290,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
178/3,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2021_0029,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
34/10,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: biological active starting materials(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
34/8,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products Special Requirements               : 7  Other: secondary packaging, QC testing & batch release(en) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other 1.4.3  Other: biological active starting materials(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UP/I-530-10/21-03/07; 381-13-08/310-21-03,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
30628,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility
23/6,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
67/4,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
21/291547,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Other terminally sterilised prepared products (microspheres/powders)(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
239/1,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
239/2,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
30586,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Preparation and storage of cell banks(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
50/4,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.2.3.8  Other
MT/014HM/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms: micropellet, non-sterile powder filling(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms: micropellet, non-sterile powder filling(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
31334,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2021/010,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/31277-4/2021,
DE_HE_01_GMP_2021_0025,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
IT/GMP/E/01-2021,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Manufacturing of non-sterile biological bulk drug substance(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
ES/081HV/21,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 1  B-lactam Antibiotics 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
NL/H 21/2027954,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/66425-8/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
142/6,
142/7,
142/8,
142/9,
DE_RP_01_GMP_2021_0015,
UP/I-530-10/21-03/05; 381-13-08/243-21-03,
DE_HE_01_GMP_2021_0037,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
30336,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/2359-2/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/36825-1/2022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/26685-1/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.14  Transdermal patches 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/826-4/2021,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: vials(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products Special Requirements               : 7  Other: Ad5-nCoV (sterile) vaccine(en) 1.5  Packaging 1.5.2  Secondary packaging
OGYÉI/826-5/2021,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
146/7,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
146/4,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
164/4,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
165/5,
62/8,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: Biological Active starting materials(en) 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA 19437 Insp GMP 19437/104762-0017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Sterile Monovalent Virus harvest Bulk Product(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Vaccine Products. Monoclonal Antibody Products/ Imfinzi (durvalumab)/ COVID-19 Vaccine AZD1222(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Vaccine Products. Monoclonal Antibody Products/ Imfinzi (durvalumab)/ COVID-19 Vaccine AZD1222(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.8  Other: Vaccine Products. Monoclonal Antibody Products/ Imfinzi (durvalumab)/ COVID-19 Vaccine AZD1222(en) 2.3  Other importation activities 2.3.1  Site of physical importation
FT085/SA/001/2021,
FT085/SA/002/2021,
FT085/SA/003/2021,
UK MIA(IMP) 42803 Insp GMP/IMP 42803/11098517-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids Special Requirements               : 3  Live Cells 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products Special Requirements               : 3  Live Cells 7  Other: Cell Banking(en) 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products Special Requirements               : 3  Live Cells 7  Other: Cell Banking(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NL/H 20/2026070A,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 20/2026070B,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
UK MIA 3473 Insp GMP 3473/15150390-0009,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.8  Other: ATMPs as stipulated in 1394/2007(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging
ES/161HV/20,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
FT084/MH/001/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
15/4,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
15/5,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA 15694 Insp GMP 15694/10617701-0013,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
BE/GMP/2020/073,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2020/074,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
VMDGMP/T108/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 34771 Insp GMP 34771/10522896-0006,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK API 17901 Insp GMP/GDP 17901/10117-0044,
127/2021/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use
128/2021/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: powders(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 3792 Insp GMP 3792/4032-0006,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
138/6,
VMDGMP/M106/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Bulk granules for veterinary premixes or addition to drinking water(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
UP/I-530-10/21-03/04; 381-13-08/256-23-08,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.8  Other solid dosage forms: Powder for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.5.1.8  Other solid dosage forms: Powder for oral suspension(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
101/10,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products
101/11,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.6  Human or animal extracted products
157/6,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products
157/7,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products
483976-13464278,
DK H 10000121,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
FIMEA/2020/005457,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 20300 Insp GMP/IMP 20300/1372957-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Cytotoxic materials, Steroids and sachets. Final formulation, filling, manufacture, packing of biolo(en) Special Requirements               : 7  Other: Cytotoxics(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Non-sterile medical products - Cytotoxic materials, Steroids and sachets. Final formulation, filling(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK MIA(IMP) 20300 Insp GMP/IMP 20300/1372957-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.3  Chewing gums 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Cytotoxic materials, steriods and sachets. Final formulation, filling,manufacture packing of biologi(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Non-sterile medical products - Cytotoxic materials, Steroids and sachets. Final formulation, filling(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA 22443 Insp GMP 22443/479651-0008,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.2.5  Other: Radiopharmaceuticals (Small volume liquids)(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.4.3  Other: Radiopharmaceuticals (Moist Heat)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 47991 Insp GMP 47991/16642630-0004,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Administration and procurement only(en)
UK MIA(IMP) 48029 Insp IMP 48029/16680966-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
16/5,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BE_01_GMP_2022_0051,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 34348 Insp GMP 34348/1333344-0004,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
108/8,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Biological active starting materials(en)"
UK MIA 21659 Insp GMP/IMP 21659/22643-0015,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 50143 Insp GMP 50143/18512376-0007,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 21659 Insp GMP/IMP 21659/22643-0015,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UP/I-530-10/21-03/01; 381-13-08/243-22-06,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA(IMP) 19054 Insp GMP/IMP 19054/340461-0016,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 46113 Insp GMP/IMP 46113/19471097-0001,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
UK MIA(IMP) 46113 Insp IMP 46113/19471102-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Ex Vivo Viral Vector(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products Special Requirements               : 7  Other: Ex Vivo Viral Vector(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA 1411 Insp GMP/GDP/IMP 1411/1767214-0012,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Small volume powders.(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA(IMP) 1411 Insp GMP/GDP/IMP 1411/1767214-0012,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK ManA 1411 Insp GMP/GDP/IMP 1411/1767214-0012,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 11709 Insp GMP/IMP 11709/22528-0011,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiopharmaceuticals(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 21923 Insp GMP 21923/12026964-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
VMDGMP/M109/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 4077 Insp GMP 4077/15191-0043,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
2021/HPF/PT/001evd,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/1320-4/2020,
VMDGMP/M105/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.17  Other: Powders(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.17  Other non-sterile medicinal products: Powders(en) 1.5.2  Secondary packaging
483963-13394471,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: sterile Bulkware / sterile API: Piperacillin Sodium and Tazobactam Sodium Mixture 8:1(en)
OGYÉI/38395-4/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/69254-1/2023,
VMDGMP/M104/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 48259 Insp GMP 48259/19416503-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 22443 Insp GMP 22443/19330983-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Radiopharmaceuticals (small volume liquids)(en) 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Radiopharmaceuticals(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared
UK MIA(IMP) 53095 Insp IMP 53095/19366905-0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products
UK GMP 22563 Insp GMP/IMP 22563/30429-0009 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK GMP 22563 Insp GMP/IMP 22563/30429-0009 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
21/10,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories Special Requirements               : 7  Other: rectal & vaginal(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: progesterone vaginal tablets(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M103/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: Powders for administration under Schedule 6(en) 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Powders for administration under Schedule 6(en) 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
VMDGMP/M107/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK API 5965 Insp GMP 5965/16804-0004 [H],
UK API 5965 Insp GMP 5965/16804-0004 [V],
UK MIA 41862 Insp GMP/GDP 43542/12302391-0005,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 726 Insp GMP 726/106704-0009,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK GMP 43637 Insp GMP/IMP 43637/18603487-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 43637 Insp GMP/IMP 43637/18603487-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 15632 Insp GMP 15632/31154-0028,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Assembly of medical devices, THR blended powder for filling into sachets(en) 1.5.2  Secondary packaging"
UK MIA 42415 Insp GMP 42415/87413-0007,"1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Drug Substance - Manufacture of biological actives (purified viral inactivated, rabbit polyclonal an(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Drug Substance - Manufacture of biological actives (purified viral inactivated, rabbit polyclonal antisera) for use in oral medicinal products(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA 44696 Insp GMP 44696/12417421-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK ManA 15632 Insp GMP 15632/31154-0028,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.17  Other: Solid multi-dose forms including powders and granules.(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA(IMP) 189 Insp IMP 189/11483-0021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BE_01_GMP_2023_0090,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 22572 Insp GMP/IMP 22572/93666-0009 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK GMP 22572 Insp GMP/IMP 22572/93666-0009 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA 16378 Insp GMP/GDP 16378/31167-0023,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UP/I-530-10/20-03/31; 381-13-08/366-23-07,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.2.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.2.1.17  Other: Powder for oral suspension and powder for oral solution(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 1.5.1.17  Other non-sterile medicinal products: Powder for oral suspension and powder for oral solution(en) Special Requirements               : 1  B-lactam Antibiotics 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M099/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: ear tags(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging
203/9,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
UK GMP 49846 Insp GMP/IMP 49846/18428305-0004 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA 40211 Insp GMP/IMP 40211/405290-0013,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Cytotoxics(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.4  Gene therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 40211 Insp GMP/IMP 40211/405290-0013,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Cytotoxics(en) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Cytotoxics(en) 1.1.1.6  Other: Suspensions(en) Special Requirements               : 7  Other: Cytotoxics(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Lyophilisation of non-sterile active ingredients / excipients for use as starting materials in solid(en) Special Requirements               : 7  Other: Cytotoxics(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Plasmid, DNA, RNA. peptides. proteins and antibodies products. This list is only indicative of the p(en) Special Requirements               : 7  Other: Cytotoxics(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging"
245/1,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK GMP 29350 Insp GMP/IMP 29350/292119-0004 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 29350 Insp GMP/IMP 29350/292119-0004 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UP/I-530-10/20-03/28; 381-13-08/366-22-08,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 42753 Insp GMP/IMP 42753/9088817-0007,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
IT/GMP/E/05/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 49794 Insp GMP 49794/19343771-0005,"2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Authorised importation activities without manufacturing activity. Site of operations, not site of ph(en)"
2020/HPF/PT/009/Evd,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
UK GMP 2795 Insp GMP/IMP 2795/5994535-0012 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.4  Biological
UK GMP 2795 Insp GMP/IMP 2795/5994535-0012 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.4  Biological
UK GMP 22481 Insp GMP 22481/117371-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
151/7,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
28536,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 46113 Insp IMP 46113/19356524-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids Special Requirements               : 3  Live Cells 1.1.1.4  Small volume liquids Special Requirements               : 3  Live Cells 1.1.1.6  Other: Gene Therapies(en) Special Requirements               : 3  Live Cells 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products Special Requirements               : 3  Live Cells 1.3.2  Batch Certification (list of product types) 1.3.2.4  Gene therapy products Special Requirements               : 3  Live Cells 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK GMP 15259 Insp GMP/IMP 15259/561958-0007 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK GMP 15259 Insp GMP/IMP 15259/561958-0007 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA 4543 Insp GMP 4543/15498-0053,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Nasal Sprays(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: manufacture of products based on botanical extracts and hormones(en) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: manufacture of products based on botanical extracts and hormones(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Nasal spray(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 4543 Insp GMP/IMP 4543/15498-0050,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Manufacture of products based on botanical extracts and hormones.(en) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.8  Other: Manufacture of products based on botanical extracts and hormones.(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
8-Nov,
UK GMP 62515 Insp GMP/IMP 62515/89520-0013 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 62515 Insp GMP/IMP 62515/89520-0013 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
BE/GMP/2020/053,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA(IMP) 21347 Insp IMP 21347/21556-0010,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA(IMP) 21347 Insp IMP 21347/4130-0026,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations
UK MIA 41103 Insp GMP/GDP 15643/352300-0016,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK API 39937 Insp GMP/GDP 39937/345063-0011,
UK MIA 15694 Insp GMP 15694/6963-0022,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK API 4 Insp GMP 4/117769-0020,
UK API 4 Insp GMP 4/117769-0020 [H],
UK API 4 Insp GMP 4/117769-0020 [V],
UK GMP 17543 Insp GMP 17543/18270974-0007,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Dry syrup products, granule products.(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Dry syrup products, granule products.(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA 14238 Insp GMP/IMP 14238/4858-0027,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 21551 Insp IMP 21551/12610385-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
DE_RP_01_GMP_2020_0029,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.17  Other: Nasal Spray(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.17  Other non-sterile medicinal products: Nasal Spray(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
39/8,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: eye drops(en) 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 14849 Insp GMP/IMP 14849/5712-0014 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 14849 Insp GMP/IMP 14849/5712-0014 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 17696 Insp GMP 17696/36548-0011,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 4  Pathogenic Organisms (Biosafety Level 3 or 4) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use Special Requirements               : 3  Live Cells 1.2.1.17  Other: Manufacture of low bioburden bulk drug substance solutions(en) Special Requirements               : 3  Live Cells 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products Special Requirements               : 3  Live Cells 1.3.1.4  Gene therapy products Special Requirements               : 3  Live Cells 1.3.1.5  Biotechnology products Special Requirements               : 3  Live Cells 1.3.1.8  Other: Antibodies,Antibody conjugates, Live microbial products, Therapeutic Virus, Plant extracted material(en) Special Requirements               : 3  Live Cells 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA 5920 Insp GMP 5920/18355055-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Site of Fiscal Importation from parent company based in Swetzerland who hold title to the stock in t(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised
UK GMP 43644 Insp GMP/IMP 43644/10698843-0005 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK GMP 43644 Insp GMP/IMP 43644/10698843-0005 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA(IMP) 42195 Insp IMP 42195/8467466-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: Batch certification of products for further processing by Hospital Trusts or Health Care centres und(en)
VMDGMP/M095/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Bulk intermediate non-sterile powder processing(en)
6.2.1-2020-039897,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Manufacture of Working Cell Bank of Sf9 cells(en)
UK ManA 15694 Insp GMP 15694/6963-0022,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK GMP 25252 Insp GMP 25252/10303054-0004,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 18532 Insp GMP/GDP/IMP 18532/29956-0047,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Vaccines(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.8  Other: Vaccines(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.8  Other: Vaccines(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.8  Other: Vaccines(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Importation, testing and release of Neuraminidase inhibitor(en)"
UK MIA 19803 Insp GMP 19803/1424017-0008,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK MIA 50674 Insp GMP 50674/19159303-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Procurement and Administration site Only(en)
UK MIA 51409 Insp GMP 51409/18822121-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 18532 Insp GMP/GDP/IMP 18532/29956-0047,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Vaccines.(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Vaccines(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.8  Other: Vaccines(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.8  Other: Vaccines(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: EU Only Comparator Products for use in Clinical Trial Studies(en)
UK MIA(IMP) 25044 Insp IMP 25044/83804-0010,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.4  Impregnated matrices 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.7  Medicinal gases 1.2.1.8  Other solid dosage forms 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.14  Transdermal patches 1.2.1.17  Other: Buccal film(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.7  Medicinal gases 1.5.1.8  Other solid dosage forms 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.1.17  Other non-sterile medicinal products: radio-labelled products/ Buccal Film(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products"
UK GMP 29769 Insp GMP/IMP 29769/303305-0007 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 29769 Insp GMP/IMP 29769/303305-0007 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 50837 Insp GMP/GDP 50837/120618-0014,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
UK MIA 20075 Insp GMP 20075/16488800-0002,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA 33336 Insp GMP/GDP 33336/8018-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 21923 Insp IMP 21923/378858-0018,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Schedule 2 controlled substances, Cytotoxics (chemotherapy), Monoclonal antibodies(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.9  Pressurised preparations 1.2.1.17  Other: Cannabidiol products(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK GMP 16929 Insp GMP 16929/8740-0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat
UK MIA 52811 Insp GMP 52811/17386-0035,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Powders and Granules(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders and granuals(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: No physical importation; fiscal movement of product between 3M EMEA Switzerland and KINDEVA DRUG DELIVERY LIMITED(en)"
UK MIA(IMP) 52811 Insp GMP/IMP 52811/17386-0032,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Dry Powder Inhalers(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.1  Site of physical importation"
DE_RP_01_GMP_2020_0020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_RP_01_GMP_2020_0021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Chewable tablets (manufacturing, primary- and secondary packaging)(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 43253 Insp GMP/IMP 43253/10085167-0005 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 43253 Insp GMP/IMP 43253/10085167-0005 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK MIA 17907 Insp GMP 17907/13988-0033,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Powders for sachets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Powders for sachets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 8596 Insp IMP 8596/18052-0034,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Partial manufacture only: formulation & spray-drying only(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
11-Feb,
12-Feb,
UK GMP 39274 Insp GMP 39274/2151508-0008,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Sunscreen(en)
UK MIA 32169 Insp GMP/IMP 32169/1562-0026,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 32169 Insp GMP/IMP 32169/1562-0026,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.9  Pressurised preparations 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.9  Pressurised preparations 1.5.1.11  Semi-solids 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 52772 Insp IMP 52772/19293009-0002,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Biological Products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products
UK MIA 17479 Insp GMP/IMP 17479/19229463-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 27376 Insp GMP/GDP 27376/112965-0011,
UK MIA(IMP) 17479 Insp GMP/IMP 17479/19229463-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.3.1.8  Other: Bulk biological API suspension(en) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.8  Other: Bulk biological API suspension(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 25274 Insp GMP/GDP/IMP 25274/29333-0015,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Pessaries(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UP/I-530-10/20-03/21; 381-13-08/337-22-10,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 49794 Insp GMP 49794/18418729-0004,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK API 29595 Insp GMP/GDP 29595/18244-0040,
UK MIA 4416 Insp GMP/GDP 4416/19135216-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification
UK MIA 20492 Insp GMP 20492/19210979-0001,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
DE_HE_01_GMP_2020_0167,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
UP/I-530-10/20-03/13; 381-13-08/318-21-06,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
26543,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2020_0164,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
VMDGMP/M098/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biologically active starting materials.  Manufacture and lyophilisation of biological seed material(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.4  Chemical 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products
118/2020/GMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 44612 Insp GMP 44612/12290578-0003,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK MIA 6719 Insp GMP/GDP 6719/8688292-0006,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA 15817 Insp GMP 15817/7147-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical"
UK API 15856 Insp GMP 15856/1769489-0018,
UK MIA 741 Insp GMP/GDP/IMP 741/1686685-0014,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 45522 Insp GMP/IMP 45522/15724840-0003,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA(IMP) 741 Insp GMP/GDP/IMP 741/1686685-0014,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
UK ManA 741 Insp GMP/GDP/IMP 741/1686685-0014,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
DE_NW_03_GMP_2020_0002,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Glucosamine sulfate(en)
sukls318673/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0072,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 51463 Insp GMP 51463/18851543-0003,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: Procurement(en)
VMDGMP/M089/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.15  Intraruminal devices 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.15  Intraruminal devices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
CH20-0507,
DE_NI_04_GMP_2020_0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms
UK GMP 42393 Insp GMP/IMP 42393/8295592-0007 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK GMP 42393 Insp GMP/IMP 42393/8295592-0007[V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK MIA(IMP) 43821 Insp IMP 43821/19218056-0001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Ex vivo viral vector(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products Special Requirements               : 7  Other: Ex vivo viral vectors(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration
DE_HE_01_GMP_2020_0054,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
UK MIA 51463 Insp GMP 51463/18851545-0003,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA 51463 Insp GMP 51463/18851547-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
VMDGMP/M094/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.6  Quality control testing 1.6.4  Biological
DE_HE_01_GMP_2020_0158,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 17907 Insp GMP/GDP 17907/10138-0025,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA 43685 Insp GMP/IMP 43685/8071768-0008,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA(IMP) 43685 Insp GMP/IMP 43685/8071768-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
CH20-0177,1 NON-COMPLIANT MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Manufacture of Active Substances(en)
UP/I-530-10/20-03/17; 381-13-08/322-20-03,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: Powder for solution for injection or infusion(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
20MPP016HVPT01,
481703-0016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/511-6/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Sachet(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Sachet(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 22899 Insp GMP 22899/37069-0009,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK MIA 22899 Insp GMP/GDP 22899/4452380-0008,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
UK MIA 42289 Insp GMP 42289/9958376-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK MIA(IMP) 21347 Insp IMP 21347/4130-0025,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations
DE_HE_01_GMP_2020_0166,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
UP/I-530-10/20-03/18; 381-13-08/322-20-03,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Powder for solution for injection or infusion(en) Special Requirements               : 1  B-lactam Antibiotics 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
CG-HU/12V/2021.,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
CG-HU/13V/2021.,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
OGYÉI/490-6/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/69580-1/2023,
20MPP015HPT01,
DE_BY_04_GMP_2020_0079,
DE_HE_01_GMP_2020_0165,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
FT083/SA/001/2020,
OGYÉI/4608-6/2020,
OGYÉI/4608-7/2020,
DE_BY_05_GMP_2020_0021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0077,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
DK H 00132520,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK MIA 48259 Insp GMP 48259/16988769-0006,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
VMDGMP/T091/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 35929 Insp GMP/GDP/IMP 35929/1113205-0012,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Labelling and packaging of sterile biological products supplied by other(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Labelling of non-sterile product(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
VMDGMP/M090/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging"
UK GMP 15351 Insp GMP/IMP 15351/18816940-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility
UK GMP 15351 Insp GMP/IMP 15351/18816940-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility
UK GMP 15351 Insp GMP/IMP 15351/38651-0021 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 15351 Insp GMP/IMP 15351/38651-0021 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK MIA 14023 Insp GMP 14023/4574-0020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.1.17  Other: Freeze dried tablet (Zydis).(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Freeze dried tablets (Zydis oral dispersible tablets)(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
26519,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.4  Gene therapy products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BY_04_GMP_2020_0172,
IT/E/API/07/2020,
OGYÉI/57443-9/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Lozenge(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Lozenge(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BY_05_GMP_2022_0002,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BY_05_GMP_2022_0003,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2020_0047,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
UK GMP 44392 Insp GMP 44392/11936715-0001,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M093/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
22/5,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: NexoBrid® Powder(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids Special Requirements               : 7  Other: NexoBrid® Gel Vehicle(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: NexoBrid Drug product  (concentrate of proteolytic enzymes enriched in bromelain)(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: NexoBrid Drug Product (concentrate of proteolytic enzymes enriched in bromelain)(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_HE_01_GMP_2020_0083,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
UK GMP 13523 Insp GMP/IMP 15390/6549-0019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
DE_HE_01_GMP_2020_0046,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
DE_HE_01_GMP_2020_0069,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK API 30812 Insp GMP/GDP 30812/336305-0003,
UK GMP 8844 Insp GMP 17170/9081-0010,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 17901 Insp GMP/GDP/IMP 17901/10117-0043,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.5  Solids and implants Special Requirements               : 7  Other: LHRH Agonist ( Zoladex)(en) 1.1.1.6  Other: LHRH Agonist ( Zoladex)(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.1.17  Other: Antioestrogen (Nolvadex)(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK MIA(IMP) 17901 Insp GMP/GDP/IMP 17901/10117-0043,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Hormones, cytotoxics/cytostatics(en)"
DE_HE_01_GMP_2020_0160,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
FT054/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets Special Requirements               : 7  Other: cytotoxics(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/55624-5/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormones(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: Hormones(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
20MPP002HPT01,
UK MIA 51897 Insp GMP 51897/19011091-0001,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA 735 Insp GMP 735/17580-0013,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0172,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA 19055 Insp GMP 19055/431097-0011,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
UK MIA(IMP) 19055 Insp GMP/GDP/IMP 19055/431097-0010,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: other.solid.dosage.forms(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Heparin and insulin(en) 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M092/2020,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other 1.4.3  Other: Biological active starting materials(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 51841 Insp GMP 51841/18986356-0002,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
IT/E/API/08/2020,
20MPP001HPT01,
FIMEA/2019/000483,
UK GMP 31559 Insp GMP 31559/13763295-0003 [H],1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 31559 Insp GMP 31559/13763295-0003 [V],1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/52808-9/2020,
UK GMP 31559 Insp GMP 31559/17782558-0004,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 10284 Insp IMP 10284/18457585-0008,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.3  Other: Automation of primary manufacturing processes(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.3  Chewing gums 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.8  Other: Microbial derived(en) 2.3  Other importation activities 2.3.1  Site of physical importation"
DE_HE_01_GMP_2020_0095,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: Nasal spray(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Nasal spray(en) 1.5.2  Secondary packaging
UK MIA 10284 Insp GMP/GDP 10284/18457585-0009,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA 20075 Insp GMP/GDP/IMP 20075/2813978-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
UK MIA(IMP) 20075 Insp GMP/IMP 20075/2813978-0006,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products
UK ManA 20075 Insp GMP/IMP 20075/2813978-0006,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
UK GMP 29943 Insp GMP 29943/309403-0006,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 4 Insp GMP/IMP 4/3848-0038,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: Cytotoxic products(en) 1.1.2.5  Other: Manufacture of parametrically released products where authorised by the individual Marketing Authori(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms Special Requirements               : 7  Other: Cephalosporins(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: Cephalosporins(en) 1.2.1.17  Other: Not specified(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: Steroids, Antibacterial Agents, Antifungal Agents(en) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
UK MIA(IMP) 4 Insp GMP/IMP 4/3848-0038,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.2.5  Other: Manufacture of parametrically released products where authorised by the individual Marketing Authori(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK ManA 4 Insp GMP/IMP 4/3848-0038,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/PT/008,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FI006/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: powders(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/28653-6/2020,
UP/I-530-10/20-03/14; 381-13-08/310-20-03,
125/2020/GMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: oral powders(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_RP_01_GMP_2020_0017,
DE_HE_01_GMP_2020_0162,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0163,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
IWSC.405.13.2020.ABU.1 WTC/0607_01_01/72,
UK MIA 101 Insp GMP/IMP 101/19062596-0005,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Ordering and Invoicing of all products, including those imported from outside of the EEA(en)"
DE_HE_01_GMP_2020_0066,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
UK GMP 25315 Insp GMP 25315/12497280-0002,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Oral contraceptives(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK GMP 25315 Insp GMP 25315/18895706-0001,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UK GMP 25315 Insp GMP 25315/2478460-0004,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Ophthalmic Solutions(en) 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
482698-12976127,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.2  Capsules, soft shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BE/GMP/2020/005,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.2  Immunological products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BY_04_GMP_2020_0042,
DE_HE_01_GMP_2020_0118,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human Plasma for fractionation(en)
OGYÉI/63107-1/2023,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/66294-8/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/74464-6/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0067,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials: human plasma for fractionation by apheresis(en)
OGYÉI/53372-6/2019,
UK GMP 15936 Insp GMP/IMP 15936/92250-0013 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK GMP 15936 Insp GMP/IMP 15936/92250-0013 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical
UK MIA(IMP) 17136 Insp GMP/IMP 17136/2431088-0007,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Cellular therapies, tissue engineered products(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.8  Other: Tissue Engineered Products(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
UK MIA(IMP) 17136 Insp GMP/IMP 17136/865904-0009,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.1.6  Other: Cellular Therapies, Tissue engineered Products, Radiopharmaceuticals (ie radiolabelled cell therapy(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.3.1.4  Gene therapy products 1.3.1.8  Other: Tissue engineered products, Radiopharmaceuticals (ie radiolabelled cell therapy product)(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Sterile cellular and tissue engineered products(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
DE_BY_04_GMP_2020_0041,
MT/007HM/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_HH_01_GMP_2020_0016,
IWSC.405.11.2020.ABU.1 WTC/0383_01_01/61,
IWSF.405.32.2020.KK.1 WTC/0383_02_01/59,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.32.2020.KK.2 WTC/0383_02_01/60,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
UK API 32930 Insp GMP 32930/761454-0008,
NL/H 20/2017455,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK MIA 2391 Insp GMP 2391/421758-0013,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
OGYÉI/53685-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 45001 Insp GMP/GDP 45001/13479670-0008,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
56/8,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
56/9,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UK MIA 45438 Insp GMP 45438/17386-0030,2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: No physical importation; fiscal movement of product between 3M EMEA Switzerland and 3M UK PLC(en)
UK MIA 94 Insp GMP 94/18415-0032,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/67128-6/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormone(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: Hormone(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IWSC.405.9.2020.ABU.1 WTC/0594_01_01/47,
IWSF.405.26.2020.KK.1 WTC/0594_01_02/46,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: raw materials used for preparing medicinal products in the pharmacy according to doctor’s prescription of Pharmacopoeia formula(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
VMDGMP/T088/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Biological active starting materials(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Biological active substance(en)
DE_HE_01_GMP_2019_0257,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials:  human plasma for fractionation(en)
IWSC.405.12.2020.ABU.1 WTC/606_01_02/70,
IWSF.405.36.2020.KK.1 WTC/0606_01_01/68,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
UK GMP 31303 Insp GMP 31303/353718-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 4102 Insp GMP/GDP/IMP 4102/92262-0013,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Granules and Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA(IMP) 4102 Insp GMP/GDP/IMP 4102/92262-0013,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Granules and Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK ManA 4102 Insp GMP/GDP/IMP 4102/92262-0013,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Granules and powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BG/GMP/2020/169,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 20/2015837,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.4  Biological
UK GMP 32917 Insp GMP/IMP 32917/448600-0015 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 32917 Insp GMP/IMP 32917/448600-0015 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.1.4  Biological
UP/I-530-10/20-03/07; 381-10-05/322-20-03,
IWSC.405.10.2020.ABU.1 WTC/0602_01_01/57,
UK API 1108 Insp GMP 1108/1893-0016 [H],
UK API 1108 Insp GMP 1108/1893-0016 [V],
UK MIA 289 Insp GMP 289/30305-0022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA 4102 Insp GMP/IMP 4102/15213-0019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Granules and Powders.(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK MIA(IMP) 4102 Insp GMP/IMP 4102/15213-0019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.17  Other: Granules and Powders(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
UK ManA 4102 Insp GMP/IMP 4102/15213-0019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: Granules and Powders(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_NW_01_GMP_2020_0014,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
OGYÉI/12446-10/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: Single dose sachet(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms: Single Dose Sachet(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK API 240 Insp GMP/IMP 240/14497-0032,
UK GMP 24881 Insp GMP 24881/41672-0007,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Specified as 􀀀Final processing steps for Primary packaging(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 240 Insp GMP/IMP 240/14497-0032,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.17  Other: Creams, ointments, ear drops, nasal drops, solutions, suspensions, emulsions and lotions. Medical De(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.3  Other: Medical Devices(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Creams, ointments, ear drops, nasal drops, solutions, suspensions, emulsions and lotions. Medical Devices(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.4  Other: Medical Devices(en)"
UK MIA(IMP) 32917 Insp IMP 32917/16466470-0003,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Mammalian Cell banks - MCB and WCB(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Mammalian Cell banks - MCB and WCB(en) 1.6  Quality control testing 1.6.1  Microbiological: sterility
OGYÉI/45770-6/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/79191-3/2021,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2019-MB-037,
IT/E/API/09/2020,
UK MIA 46101 Insp GMP/IMP 46101/15378211-0004,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.8  Other: Import of Unlicenced medicinal products for named patient supply.(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Import of Unlicenced medicinal products for named patient supply.(en)
UK MIA(IMP) 46101 Insp GMP/GDP/IMP 46101/15378211-0004,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.8  Other: Import of Unlicenced medicinal products for named patient supply(en) 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Import of Unlicenced medicinal products for named patient supply(en)
DE_BE_01_GMP_2019_0043,
UK GMP 44733 Insp GMP 44733/12469181-0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 116 Insp GMP/GDP 116/18507-0050,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.2.5  Other: Manufacture of parametrically released products where authorised by the individual Marketing Authori(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
VMDGMP/M087/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.8  Other solid dosage forms 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 31644 Insp GMP/GDP/IMP 31644/362376-0011,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA 31644 Insp GMP/GDP/IMP 31644/93802-0014,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised
UK MIA(IMP) 31644 Insp GMP/GDP/IMP 31644/362376-0011,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation
UK MIA(IMP) 31644 Insp GMP/GDP/IMP 31644/93802-0014,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
DE_BY_04_GMP_2021_0064,
19MPP091HPT01,
DE_BE_01_GMP_2019_0042,
482031-0005,
DE_HH_01_GMP_2020_0031,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Substances of microbial origin(en)
IT/E/API/06/2020,
2020-231,
MT/025HM/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/57046-6/2019,
UK GMP 20517 Insp GMP/IMP 20517/18990311-0002 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
UK GMP 20517 Insp GMP/IMP 20517/18990311-0002 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility
DE_HE_01_GMP_2020_0022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
UK MIA 49160 Insp GMP/GDP 49160/18209389-0007,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation"
UK MIA(IMP) 49160 Insp IMP 49160/18209389-0006,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
UK API 8170 Insp GMP 8170/17726-0007,
482314-0003,
DE_BY_04_GMP_2020_0078,
2020-002,
DE_HE_01_GMP_2020_0028,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Other Biological active starting materials: human plasma for fractionation(en)
DE_HH_01_GMP_2020_0004,
DE_HH_01_GMP_2021_0003,
IT/E/API/05/2020,
IT/GMP/E/2/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
OGYÉI/44607-6/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: Dry Syrup, Singel Dose Sachet(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: Dry Syrup, Singel Dose Sachet(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
409-8/2019-6,
482505-0002,
BE/GMP/2019/093,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: non sterile excipient (recombinant human hyaluronidase)(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BG/GMP/2021/184,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0049,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Preparation of mixture of Magnesium carbonate and starch(en)
DE_SH_01_GMP_2020_0033,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/32896-6/2019,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK API 27886 Insp GMP 17624/9727-0001,
UK GMP 24616 Insp GMP/IMP 24616/25448-0034 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
UK GMP 24616 Insp GMP/IMP 24616/25448-0034 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
134/5,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 42752 Insp GMP/IMP 42752/9088736-0004,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 42752 Insp GMP/IMP 42752/9088736-0004,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.4  Other: Class I and IIa Medical Devices, food and cosmetic films(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.3  Biological medicinal products 2.2.3.8  Other: Vaccines inactivated and live(en)"
UK MIA(IMP) 51381 Insp GMP/IMP 51381/18816730-0001,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
UP/I-530-10/20-03/05; 381-10-05/162-20-03,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.3  Moist heat 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2020_0014,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
VMDGMP/M085/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.9  Pressurised preparations 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.9  Pressurised preparations 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
409-9/2019-7,
6.2.1-2019-052854,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Sampling, dispensing and storage of raw materials inclusive API(en)"
DE_HE_01_GMP_2019_0240,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
IT/GMP/E/1/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.1.8  Other: intermediate plasma fractions(en) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DK H 00126119,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other Special Requirements               : 5  Radiopharmaceuticals 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 5  Radiopharmaceuticals 1.2.1.6  Liquids for internal use Special Requirements               : 5  Radiopharmaceuticals 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 5  Radiopharmaceuticals 1.5.1.6  Liquids for internal use Special Requirements               : 5  Radiopharmaceuticals 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
FT068/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.1.6  Other: Dry powders for injection(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA 4509 Insp GMP/GDP 4509/31333-0019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA 4509 Insp GMP/GDP 4509/31333-0020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.6  Quality control testing 1.6.3  Chemical/Physical
6.2.1-2019-052206,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Release of IMP manufactured at Fisher Clinical Services, Indianapolis(en) 1.6  Quality control testing 1.6.3  Chemical/Physical"
DE_HE_01_GMP_2019_0239,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
UK MIA(IMP) 42563 Insp GMP/IMP 42563/8641729-0005,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products
DE_BE_01_GMP_2020_0017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
001/2020/RO,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: cytostatics/cytotoxics(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: cytostatics/cytotoxics(en) 1.2.1.17  Other: film-coated tablets(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: cytostatics/cytotoxics(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: cytostatics/cytotoxics(en) 1.5.1.17  Other non-sterile medicinal products: film-coated tablets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BE/GMP/2019/108,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.8  Other: Bulk drug substance(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2023/064,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
FT082/MH/001/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IS/03/20,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.2.1.17  Other: Powders for reconstitution(en) 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
UK MIA(IMP) 17857 Insp IMP 17857/14285-0008,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: Sachets, powder, Cytostatics.(en) 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.8  Other: Pharmaceutical dosage forms containing peptides, proteins, enzymes or other materials from human, an(en) 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.3  Biological medicinal products 2.2.3.6  Human or animal extracted products"
DE_HH_01_GMP_2020_0025,
MT/0013HM/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
MT/006/HM/2021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
6.2.1-2019-053938,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging"
92/5,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.6  Electron beam 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.17  Other non-sterile medicinal products: Fibrin pad(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
MT/006/HM/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
VMDGMP/M086/2020,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
OGYÉI/45078-8/2019,
DE_HH_01_GMP_2021_0020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Sterile ophthalmic solution for topical use.(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DE_HE_01_GMP_2019_0237,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0009,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
DE_HE_01_GMP_2020_0012,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials: human Plasma for fractionation(en)
NL/H 19/2015835,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration
UK MIA(IMP) 41467 Insp IMP 41467/10573410-0006,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
191/6,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
191/7,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
